Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 21, 1998

View Archived Issues

IL-4(38-37)-PE38KDEL treatment results in complete regression of human glioblastoma tumors

Company Profile: Prolifix

PSA is a useful indicator of prostate cancer in finasteride-treated patients

Roche: half-year 1998 highlights

EntreMed signs CRADA with NCI to advance Endostatin protein studies

FDA clears new product for facilitating GTR procedures

NCI to sponsor pivotal phase III trials of AEterna's Neovastat

MedImmune and Chiron enter agreement on vaccine adjuvant technology

Pacific Pharmaceuticals initiates NCI-sponsored trial at Duke University Medical Center

Phase IIb trial results confirm efficacy and safety of INKP-100 for colonoscopy

Ixion's method of producing islet cells to be covered by U.S. patent

Anergen in-licenses MHC II-peptide complex with potential applications in MS

Novel antiinflammatory azulenes disclosed by Kotobuki

Japan Energy presents new HIV protease inhibitors

Meiji Seika's new macrolides active against Gram-positive microorganisms

Pfizer identifies glycogen phosphorylase inhibitor as potent antidiabetic agent

Preparation and antibacterial activity of new cephems disclosed by Otsuka

Sankyo patents series with dual NK1/NK2-antagonist activity

International team reports discovery of novel immunostimulants

Orion receives EU approval to market Parkinson's disease treatment

Another treatment option added to the anti-HIV arsenal: efavirenz gets FDA approval

Bayer strengthens diagnostics division with acquisition of Chiron subsidiary

New cardioprotectant from RPR shows potential in treating acute myocardial infarction

Infasurf product launch delayed again

ACAT inhibitor synthesized at Slovakofarma and presented at EFMC symposium

Cognition enhancer on the clinical track at Dainippon

Shareholders approve acquisition; AVI BioPharma up and running

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...